Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 19 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 19, Issue 4 (December 2016) In this issue Reviews Original Articles Corrigendum Also new AOP Advertisement Sign up for e-alerts Twitter Recommend to your library Web feed Subscribe Advertisement Take a look at our new Editor's Choice page Prostate Cancer and Prostatic Diseases is delighted to share with you an Editor's Choice selection of key papers that highlight some of the best current research published in the journal. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers, and have been selected because readers will find them particularly interesting or useful.  See the latest Editor's Choice articles     Reviews Top A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients OPEN J L Kiwata, T B Dorff, E T Schroeder, M E Gross and C M Dieli-Conwright Prostate Cancer Prostatic Dis 2016 19: 323-332; advance online publication, June 28, 2016; 10.1038/pcan.2016.25 Abstract | Full Text A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients C Jin, Y Fan, Y Meng, C Shen, Y Wang, S Hu, C Cui, T Xu, W Yu and J Jin Prostate Cancer Prostatic Dis 2016 19: 333-339; advance online publication, September 6, 2016; 10.1038/pcan.2016.35 Abstract | Full Text The very-high-risk prostate cancer: a contemporary update R Mano, J Eastham and O Yossepowitch Prostate Cancer Prostatic Dis 2016 19: 340-348; advance online publication, September 13, 2016; 10.1038/pcan.2016.40 Abstract | Full Text Original Articles Top Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells OPEN S Gupta, A Weston, J Bearrs, T Thode, A Neiss, R Soldi and S Sharma Prostate Cancer Prostatic Dis 2016 19: 349-357; advance online publication, June 28, 2016; 10.1038/pcan.2016.21 Abstract | Full Text Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis Y Zhao, J J Lv, J Chen, X B Jin, M W Wang, Z H Su, L Y Wang and H Y Zhang Prostate Cancer Prostatic Dis 2016 19: 358-366; advance online publication, July 19, 2016; 10.1038/pcan.2016.29 Abstract | Full Text Tumor features and survival after radical prostatectomy among antidiabetic drug users R M Joentausta, P M Kujala, T Visakorpi, T L J Tammela and T J Murtola Prostate Cancer Prostatic Dis 2016 19: 367-373; advance online publication, August 9, 2016; 10.1038/pcan.2016.32 Abstract | Full Text Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients OPEN R B Den, M Santiago-Jimenez, J Alter, M Schliekelman, J R Wagner, J F Renzulli II, D I Lee, C G Brito, K Monahan, B Gburek, N Kella, G Vallabhan, F Abdollah, E J Trabulsi, C D Lallas, L G Gomella, T L Woodlief, Z Haddad, L L C Lam, S Deheshi, Q Wang, V Choeurng, M du Plessis, J Jordan, B Parks, H Shin, C Buerki, K Yousefi, E Davicioni, V R Patel and N L Shah Prostate Cancer Prostatic Dis 2016 19: 374-379; advance online publication, August 30, 2016; 10.1038/pcan.2016.38 Abstract | Full Text Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer? L E Howard, A M De Hoedt, W J Aronson, C J Kane, C L Amling, M R Cooperberg, M K Terris, C H Divers, A Valderrama and S J Freedland Prostate Cancer Prostatic Dis 2016 19: 380-384; advance online publication, July 5, 2016; 10.1038/pcan.2016.26 Abstract | Full Text Can nomograms improve our ability to select candidates for active surveillance for prostate cancer? V Iremashvili, M Manoharan, D J Parekh and S Punnen Prostate Cancer Prostatic Dis 2016 19: 385-389; advance online publication, July 19, 2016; 10.1038/pcan.2016.27 Abstract | Full Text A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment M A Liss, J M Schenk, A V Faino, L F Newcomb, H Boyer, J D Brooks, P R Carroll, A Dash, M D Fabrizio, M E Gleave, P S Nelson, M L Neuhouser, J T Wei, Y Zheng, J L Wright, D W Lin and I M Thompson Prostate Cancer Prostatic Dis 2016 19: 390-394; advance online publication, July 19, 2016; 10.1038/pcan.2016.28 Abstract | Full Text Increasing incidence of metastatic prostate cancer in the United States (2004–2013) A B Weiner, R S Matulewicz, S E Eggener and E M Schaeffer Prostate Cancer Prostatic Dis 2016 19: 395-397; advance online publication, July 19, 2016; 10.1038/pcan.2016.30 Abstract | Full Text Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer R R McKay, L Werner, M Fiorillo, M Nakabayashi, P W Kantoff and M-E Taplin Prostate Cancer Prostatic Dis 2016 19: 398-405; advance online publication, August 9, 2016; 10.1038/pcan.2016.31 Abstract | Full Text Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database C Gilfrich, H Leicht, C Fahlenbrach, E Jeschke, G Popken, J U Stolzenburg, L Weißbach, C Zastrow and C Günster Prostate Cancer Prostatic Dis 2016 19: 406-411; advance online publication, August 9, 2016; 10.1038/pcan.2016.33 Abstract | Full Text Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013 C Groeben, R Koch, M Baunacke, M P Wirth and J Huber Prostate Cancer Prostatic Dis 2016 19: 412-416; advance online publication, August 23, 2016; 10.1038/pcan.2016.34 Abstract | Full Text Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis K Lahdensuo, A Rannikko, V-J Anttila, A Erickson, A Pätäri-Sampo, M Rautio, H Santti, E Tarkka, M Vaara and K Huotari Prostate Cancer Prostatic Dis 2016 19: 417-422; advance online publication, August 16, 2016; 10.1038/pcan.2016.36 Abstract | Full Text Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort H Wadhwa, M K Terris, W J Aronson, C J Kane, C L Amling, M R Cooperberg, S J Freedland and M R Abern Prostate Cancer Prostatic Dis 2016 19: 423-428; advance online publication, October 4, 2016; 10.1038/pcan.2016.45 Abstract | Full Text Corrigendum Top A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients C Jin, Y Fan, Y Meng, C Shen, Y Wang, S Hu, C Cui, T Xu, W Yu and J Jin Prostate Cancer Prostatic Dis 2016 19: 429; advance online publication, September 27, 2016; 10.1038/pcan.2016.48 Full Text Advertisement Meet the Editors of Prostate Cancer and Prostatic Diseases The Editors of Prostate Cancer and Prostatic Diseases are internationally renowned researchers at the top of their field. Our team of experts are widely published, with their breadth of knowledge and experience making them key figures in the field of prostate cancer and prostatic disease. Find out more about our Editors, their specific areas of expertise and whether your next paper is suitable for PCAN on our Meet the Editors page. Learn more about submitting your research     Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.